CN1370413A - Formula milk and processing method thereof - Google Patents
Formula milk and processing method thereof Download PDFInfo
- Publication number
- CN1370413A CN1370413A CN 01107830 CN01107830A CN1370413A CN 1370413 A CN1370413 A CN 1370413A CN 01107830 CN01107830 CN 01107830 CN 01107830 A CN01107830 A CN 01107830A CN 1370413 A CN1370413 A CN 1370413A
- Authority
- CN
- China
- Prior art keywords
- thymin
- dairy products
- rotavirus antibody
- formula milk
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003672 processing method Methods 0.000 title claims abstract description 24
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 21
- 241000702670 Rotavirus Species 0.000 claims abstract description 42
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 37
- 229930091371 Fructose Natural products 0.000 claims abstract description 37
- 239000005715 Fructose Substances 0.000 claims abstract description 37
- 229920000642 polymer Polymers 0.000 claims abstract description 36
- 235000013365 dairy product Nutrition 0.000 claims abstract description 24
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims description 56
- 239000000203 mixture Substances 0.000 claims description 30
- 238000004659 sterilization and disinfection Methods 0.000 claims description 24
- 239000002994 raw material Substances 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 20
- 235000013336 milk Nutrition 0.000 claims description 19
- 239000008267 milk Substances 0.000 claims description 19
- 210000004080 milk Anatomy 0.000 claims description 19
- 238000012545 processing Methods 0.000 claims description 16
- 108091005804 Peptidases Proteins 0.000 claims description 12
- 239000004365 Protease Substances 0.000 claims description 12
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 6
- 238000007796 conventional method Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 235000020185 raw untreated milk Nutrition 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 2
- 230000036737 immune function Effects 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- 210000001835 viscera Anatomy 0.000 abstract description 2
- 239000000724 thymus hormone Substances 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 description 20
- 239000000843 powder Substances 0.000 description 15
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 12
- 229940107187 fructooligosaccharide Drugs 0.000 description 12
- 229920000377 Sinistrin Polymers 0.000 description 11
- 235000013322 soy milk Nutrition 0.000 description 5
- 230000036039 immunity Effects 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000008939 whole milk Nutrition 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 208000019637 Infantile Diarrhea Diseases 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- LKDRXBCSQODPBY-ZXXMMSQZSA-N alpha-D-fructopyranose Chemical compound OC[C@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ZXXMMSQZSA-N 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
Landscapes
- Dairy Products (AREA)
Abstract
The invention relates to formula milk and a processing method thereof. The main technical proposal is that thymic hormone is added into the prior dairy product, and fructose polymer and rotavirus antibody can also be contained in the dairy product. Thymic hormone is a protein derivative, which is an active substance extracted from animal viscera and can produce the effect of enhancing the immune function of human bodies after long-term administration. It is combined with dairy products, and can be easily taken and absorbed by human body, and promote health of human body. The thymic hormone, the fructose polymer and the rotavirus antibody can comprehensively act on a human body, improve the overall quality of the human body and are particularly suitable for infants, children and middle-aged and elderly people.
Description
The present invention is a kind of formula milk and processing method thereof.
The suitable microbial ecosystem that has a complexity in the human intestine, this system contains each a large amount of bacterioids.These microbiotas play an important role to infant and other people health.Under the situation of normal flora imbalance, harmful microorganism can cause or increase the danger of infecting, as serious diarrhoea and gastrointestinal disease etc.On the other hand, beneficial microbe such as Bifidobacterium and Bacillus acidi lactici can generate carbohydrate by the material that contains energy that ferments in enteron aisle, thereby improve the health status of human body.According to close biological theory, fructose polymer (comprising polyfructosan and fructo-oligosaccharide) is not for human digestive but can influences the special foods composition of probio quantity in the human body.Experiment showed, that they and they fermentate can promote growth of probio and the metabolism of promotion probio, can increase the probio quantity in the human feces behind the absorption human body, therefore is that the useful of human diet replenished.Added the generation of fructo-oligosaccharide in the existing product, but its effect is single, can not improve the resistance against diseases of human body all sidedly in order to minimizing infantile diarrhea.
The objective of the invention is to: a kind of raising human body particularly interior Bifidobacterium of infants and Bacillus acidi lactici are provided, improve body immunity and then reach the formula milk of protecting healthy effect.
Technical scheme of the present invention is to add thymin in dairy products, and the content of thymin generally is no more than 1%.
Thymin is a kind of derivative of protein, and it is the active material that extracts in the internal organs by animal, takes for a long time to produce the effect that strengthens immunologic function to human body.It and dairy products can help taking and absorbing of people together, promote that the people's is healthy.
The dairy products that adopted among the present invention can be existing various finished product, as skimmed milk power, add the dairy products that are applicable to the baby of corresponding raw material or be applicable to person in middle and old age's dairy products and the pure dairy products handled through sterilization etc. etc., wherein also comprised the dairy products that add rotavirus antibody or fructose polymer.Contain the present invention of thymin, fructose polymer and rotavirus antibody, can comprehensive function in human body, improve people's total quality, be specially adapted to baby, children and the elderly.
For the present invention who adds fructose polymer and rotavirus antibody, wherein the weight ratio of dairy products, fructose polymer, rotavirus antibody and thymin is generally: 90.0-99.0: 0.5-5.0: 0.01-4.5: 0.01-1.0.Employed fructose polymer can adopt the mixture of fructo-oligosaccharide or polyfructosan or two class fructose polymers etc. among the present invention.
Facts have proved that polyfructosan and fructo-oligosaccharide all can promote the growth of the probio of human body effectively.And rotavirus antibody; in the energy and enteron aisle in virus; both are in conjunction with promoting mutually; more help the growth of profitable strain in the enteron aisle; can also improve simultaneously the immunity that the enteron aisle opposing is infected; more effectively play the healthy of antidiarrheal, promotion and protection infant, or improve other users' immunity.
Finished product of the present invention can be liquid state, also can be solid-state.For adding fructose polymer 0.5-5 gram in the general every liter of milk of liquid form product, rotavirus antibody 0.01-5 gram, thymin 0.01-1 gram; Its optimum range is: 95: 4: 0.5: 0.5.Above-mentioned liquid form product can be existing various liquid milk product.Dairy products for powdery generally will add fructose polymer 0.5-5 gram, rotavirus antibody 0.1-5 gram, thymin 0.1-1.5 gram in per 150 gram dairy products.
As required, also can add other material among the present invention, as B B-complex, composite mineral matter and other essential nutrient.
According to the difference of raw material and product form, the present invention has different processing methods:
1, when the dairy products raw material is liquid state, carry out preliminary treatment according to a conventional method after at first raw milk being checked and accepted, be heated to 65-75 ℃ then and kill the growth type bacterium, again with its cooling, add fructose polymer, rotavirus antibody and thymin then in proportion, at 120-130 ℃ high-temperature sterilization, make finished product at last.Used rotavirus antibody and thymin should be the raw materials that has carried out acidproof, resistant protease and heat-resisting processing, hereinafter referred to as the stable type raw material, are called the plain edition raw material without the raw material of acidproof, resistant protease and heat-resisting processing.If be the plain edition raw material, its above-mentioned processing procedure is undertaken by prior art.
Perhaps according to a conventional method it is carried out disinfection and relevant processing, then it is concentrated, add fructose polymer, rotavirus antibody and thymin and mix, again it is carried out drying and make powdery, sieve and make finished product.
2, when the dairy products raw material is powdery, in proportion it is mixed under aseptic condition with fructose polymer, rotavirus antibody and thymin, make finished product.
Below in conjunction with embodiment the present invention is elaborated.
Embodiment one:
Present embodiment adds 0.2 gram stable type thymin by liquid plain chocolate and stable type thymin by every liter of plain chocolate and makes.Its processing method is that both are fully mixed, then 125 the degree temperature under the sterilization and make.
Embodiment two:
Present embodiment is made by skimmed milk power and plain edition thymin, and both weight ratios are: 99.5: 0.5, both all made sterilization treatment before mixing.Its processing method is that both are fully mixed under aseptic condition in proportion, wears into fine powder and makes finished product, carries out packing.
Embodiment three:
Present embodiment is made by baby milk and plain edition thymin, and both weight ratios are: 99.99: 0.01.Its processing method is: above-mentioned two kinds of compositions are carried out acidproof, resistant protease and heat-resisting processing by prior art respectively, make the stable type raw material, two kinds of compositions are mixed, at 120 ℃ of following high-temperature sterilizations, wear into fine powder and make finished product.
Embodiment four:
Present embodiment is to be made by the thymin of person in middle and old age's milk powder and stable type, and both weight ratios are: 99.0: 1.0.Its processing method is: person in middle and old age's milk powder is heated to 65 ℃ and kills the growth type bacterium, again with its cooling, adds thymin in proportion under aseptic condition then, and it is mixed, and makes finished product.
Embodiment five:
Present embodiment is made by soymilk powder and plain edition thymin, and both weight ratios are: 99.2: 0.8.Its processing method is: soymilk powder is heated to 75 ℃ kills the growth type bacterium, thymin is carried out acidproof resistant protease and heat-resisting processing by prior art, then above-mentioned two kinds of compositions are mixed, again with it at 130 ℃ of following high-temperature sterilizations, make finished product.
Embodiment six:
Present embodiment is made by liquid milk and plain edition thymin and fructose polymer.Wherein should add thymin gram 0.6 in every liter of liquid milk, fructose polymer 3 grams.Fructose polymer in the present embodiment is the mixture of polyfructosan and fructo-oligosaccharide.The processing method of present embodiment is: liquid milk is heated to 70 ℃ kills its growth type bacterium, thymin is carried out acidproof, resistant protease and heat-resisting processing.After above-mentioned three kinds of compositions are mixed in proportion, under 130 ℃ temperature, carry out high-temperature sterilization and make finished product.
Embodiment seven:
Present embodiment is made up of skimmed milk power, plain edition thymin and fructose polymer, and fructose polymer wherein is the mixture of polyfructosan and fructo-oligosaccharide.The weight ratio of above-mentioned three kinds of raw materials is: 96: 0.05: 2.5.Its processing method is: three kinds of raw materials are carried out sterilization treatment, three kinds of raw materials are mixed under aseptic condition again and make finished product.
Embodiment eight:
Present embodiment is made by baby milk, plain edition thymin and fructo-oligosaccharide, the weight ratio of above-mentioned each composition is: 95: 0.5: 4.5, concrete processing method is: baby milk, thymin and fructo-oligosaccharide are carried out conventional sterilization treatment, then three kinds of powder raw materials are fully mixed under aseptic condition and make finished product.
Embodiment nine:
Present embodiment is made by person in middle and old age's milk powder, thymin and polyfructosan, and the weight ratio of above-mentioned each composition is: 96: 0.7: 5.Its preparation method is: above-mentioned three kinds of raw materials are carried out sterilization treatment, and thymin is carried out the processing of heat-resisting, acidproof and resistant protease, then three kinds of raw materials are mixed, again finished product is made in its sterilization under the temperature of 125 degree.
Embodiment ten:
Present embodiment is made by soymilk powder, thymin and fructose, and fructose wherein is the mixture of fructo-oligosaccharide and polyfructosan, and the weight ratio of above-mentioned each composition is: 90: 0.3: 1.The processing method of present embodiment is identical with embodiment nine, no longer repeats here.
Embodiment 11:
Present embodiment is made by liquid milk, thymin and rotavirus antibody, adds each 1 gram of thymin and rotavirus antibody in every liter of liquid milk.Its processing method is: thymin and rotavirus antibody are carried out acidproof, resistant protease and heat-resisting processing respectively, then three kinds of raw materials are fully mixed, again it is carried out sterilization treatment under the temperature of 125 degree and make finished product.
Embodiment 12:
Present embodiment is made by whole milk powder, thymin, rotavirus antibody, the weight ratio of above-mentioned each composition is: 98: 1: 1, its processing method is: thymin and rotavirus antibody are carried out acidproof, resistant protease and heat-resisting processing, then three kinds of raw materials are mixed, high-temperature sterilization is made finished product under the temperature of 130 degree at last.
Embodiment 13:
Present embodiment is made by baby milk, thymin, rotavirus antibody, and the weight ratio of above-mentioned each composition is: 97: 0.7: 0.7.Its processing method is: select stable type thymin and rotavirus antibody for use, itself and baby milk are mixed under aseptic condition in proportion and make finished product.
Embodiment 14:
Present embodiment is made by person in middle and old age's milk powder, stable type thymin and stable type rotavirus antibody, and the weight ratio of above-mentioned three kinds of compositions by 90: 0.6: 0.01 mixed, and is making finished product behind the high-temperature sterilization under the temperature of 120 degree then.
Embodiment 15:
Present embodiment is made by soymilk powder, plain edition thymin and plain edition rotavirus antibody, and the weight ratio of above-mentioned each composition is: 93: 0.03: 3.Thymin and rotavirus antibody are carried out acidproof, resistant protease and heat-resisting processing earlier, then above-mentioned three kinds of raw materials are mixed in proportion, at last with it at 130 degree high-temperature sterilization and make finished product under temperature.
Embodiment 16:
Present embodiment is made in the ratio that every liter of liquid milk adds 0.4 gram thymin, 2 gram rotavirus antibodies and 2 gram fructose polymers by liquid milk, plain edition thymin and plain edition rotavirus antibody and fructose polymer, and fructose polymer wherein is the mixture of polyfructosan and fructo-oligosaccharide.Specifically add man-hour, want earlier thymin and rotavirus antibody are carried out acidproof, resistant protease and heat-resisting processing, and liquid milk is heated to 70 degree carries out disinfection, then various compositions are fully mixed, at last finished product is made in its sterilization under the temperature of 125 degree.
Embodiment 17:
Present embodiment is made in the ratio that every liter of liquid milk adds 0.6 gram thymin, 0.08 gram rotavirus antibody and 5 gram fructose polymers by liquid milk, stable type thymin and stable type rotavirus antibody and fructose polymer, and fructose polymer wherein is the mixture of polyfructosan and fructo-oligosaccharide.Specifically add man-hour, earlier liquid milk is heated to 70 degree and carries out disinfection, then various compositions are fully mixed, then it is condensed into powdery, at last it is being made finished product after sterilization under temperature of 120 degree.
Embodiment 18:
Present embodiment is made by whole milk powder, plain edition thymin, fructose polymer and plain edition rotavirus antibody, and the weight ratio of above-mentioned each composition is: 94: 1.2: 5: 0.5.Its processing method is: earlier each composition is carried out sterilization treatment, under aseptic condition each composition mixed then and make finished product.
Embodiment 19:
Fructose polymer and stable type rotavirus antibody that present embodiment is formed by baby milk, stable type thymin, by polyfructosan and fructo-oligosaccharide are made, and the weight ratio of above-mentioned each composition is: 150: 0.04: 4: 5.Its processing method is: after each composition is mixed in proportion, making finished product after the sterilization under the temperature of 125 degree.
Embodiment 20:
Present embodiment is made by person in middle and old age's milk powder, plain edition thymin, fructose polymer and plain edition rotavirus antibody, and the weight ratio of above-mentioned each composition is: 150: 0.1: 0.5: 3.Earlier thymin and rotavirus antibody are carried out the processing of heat-resisting, acidproof and resistant protease, again four kinds of raw materials are mixed, then it is carried out the high-temperature sterilization processing and makes finished product under the temperature of 130 degree.
Embodiment 21:
Present embodiment is made by soymilk powder, thymin, polyfructosan and rotavirus antibody, and the weight ratio of above-mentioned each composition is: 150: 0.3: 0.8: 1.5.The processing method of present embodiment is identical with embodiment 17.
Claims (10)
1, a kind of formula milk is characterized in that: it is the mixture of dairy products and thymin, and wherein the content of thymin is no more than 1%.
2, formula milk according to claim 1 is characterized in that: contain fructose polymer in the said dairy products.
3, formula milk according to claim 1 and 2 is characterized in that; Contain rotavirus antibody in the said dairy products.
4, formula milk according to claim 3, it is characterized in that: it is mixed and made into by dairy products and fructose polymer and rotavirus antibody and thymin, wherein, the weight ratio of dairy products, fructose polymer and rotavirus antibody and thymin content is 90.0-99.0: 0.5-5.0: 0.01-4.5: 0.01-1.0.
5, formula milk according to claim 4 is characterized in that: said dairy products are liquid, wherein add fructose polymer 0.5-5 gram in every liter of liquid milk, rotavirus antibody 0.01-5 gram, thymin 0.01-1.0 gram.
6, formula milk according to claim 4 is characterized in that: said dairy products are powdery solid, add fructose polymer 0.5-5 gram in wherein per 150 gram dairy products, rotavirus antibody 0.1-5 gram, thymin 0.1-1.5 gram.
7, the processing method of above-mentioned formula milk, it is characterized in that: carry out preliminary treatment according to a conventional method after raw milk is checked and accepted, be heated to 65-75 ℃ of kill bacteria then, again with its cooling, add fructose polymer and rotavirus antibody then in proportion, under 120-130 ℃ high temperature, sterilize at last, make finished product.
8, the processing method of formula milk according to claim 7 is characterized in that: rotavirus antibody and thymin are carried out acidproof, resistant protease and heat-resisting processing before mixing.
9, the processing method of above-mentioned formula milk is characterized in that: adopting sterile powdered dairy products is raw material, in proportion it is mixed with the fructose polymer that killed bacterium, rotavirus antibody and thymin, makes finished product.
10, the processing method of above-mentioned formula milk, it is characterized in that: the employing liquid diary product is a raw material, according to a conventional method it is carried out disinfection and relevant processing, then it is concentrated, fully mix after adding fructose polymer and rotavirus antibody, again it is carried out drying and make powdery, make finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01107830 CN1370413A (en) | 2001-02-23 | 2001-02-23 | Formula milk and processing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01107830 CN1370413A (en) | 2001-02-23 | 2001-02-23 | Formula milk and processing method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1370413A true CN1370413A (en) | 2002-09-25 |
Family
ID=4656735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01107830 Pending CN1370413A (en) | 2001-02-23 | 2001-02-23 | Formula milk and processing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1370413A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101072508B (en) * | 2004-10-06 | 2011-04-13 | 农业生物技术有限公司 | Milk production method |
-
2001
- 2001-02-23 CN CN 01107830 patent/CN1370413A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101072508B (en) * | 2004-10-06 | 2011-04-13 | 农业生物技术有限公司 | Milk production method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1153575C (en) | Pharmaceutical preparation comprising lactobacillus casei phamnosus | |
| TWI574633B (en) | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin | |
| CN1178592C (en) | Drinks and foods capable of eliminating helicobacter pylori | |
| EP1609852B1 (en) | Bifidobacteria and preparations containing them | |
| EP2547348B1 (en) | Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions | |
| KR101164876B1 (en) | Broccoli production fermented by lactic acid bacteria, which is anti-inflammatory and anti-Helicobacter pylori and method for preparation thereof | |
| CN1800348A (en) | Multifunctional probiotic preparation and its preparation method | |
| US20050106132A1 (en) | Growth promoting prebiotic for lactobacillus dietary supplements | |
| CN105535580A (en) | A biological agent for improving human body intestinal floras and a preparing method thereof | |
| CN1177636A (en) | Bacterial stain of bacillus subtilis and application thereof | |
| KR20160026280A (en) | Non-antibiotics pellet feed for raising animal | |
| PL212096B1 (en) | New strains of bifidobacterium having the ability to produce glutamine | |
| CN1454901A (en) | Gynaecological anti-infective specificity IgY and its combined preparation | |
| CN1238054C (en) | Biotechnological formulation for suppressing and killing helicobacter pylori, its preparation and use | |
| CN1370413A (en) | Formula milk and processing method thereof | |
| US5741494A (en) | Immunopotentiative and infection-protective agent containing bacillus and egg white | |
| CN1799378A (en) | Human colostrum-simulated biological milk powder | |
| EA022278B1 (en) | Pharmaceutical composition for the prophylaxis and treatment of infectious and non-infectious diarrhoea | |
| JP2001048796A (en) | Lactobacillus extract and killed bacterium cell powder which are originated from enteric bacterium and have function for preventing infectious disease and function for reducing disease related to immunity and their application to food | |
| CN1177637A (en) | Preparation of living bacillus subtilis and preparation method thereof | |
| CN108077935A (en) | Nurse one's health middle-aged and elderly people's function of intestinal canal microbial inoculum and its preparation method and application | |
| CN1596123A (en) | Interferon therapeutic effect-potentiating agents | |
| CN1046099A (en) | The tonsillitic pharmaceutical preparation of a kind of treatment | |
| Wang et al. | Application of Weizmannia coagulans in the medical and livestock industry | |
| CN100339069C (en) | Formulation comprising thymol useful in treatment of drug resistant bacterial infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| ASS | Succession or assignment of patent right |
Owner name: JINAN KEYI HUMAN BIOLOGY ENGINEERING CO., LTD. Free format text: FORMER OWNER: SHANDONG KEYIREN BIOENGINEERING CO., LTD. Effective date: 20020808 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20020808 Applicant after: Ji'nan Keyi Bioengineering Co., Ltd. Applicant before: Jinan Keyiren Bioengineering Co., Ltd. |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |